These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2818245)

  • 1. Cerebellar ataxia.
    Klein P
    Arch Neurol; 1989 Nov; 46(11):1166. PubMed ID: 2818245
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of fast single-joint and multijoint movements in cerebellar cortical atrophy: failure of L-hydroxytryptophan to improve cerebellar ataxia.
    Manto M; Hildebrand J; Godaux E; Roland H; Blum S; Jacquy J
    Arch Neurol; 1997 Oct; 54(10):1192-4. PubMed ID: 9341562
    [No Abstract]   [Full Text] [Related]  

  • 3. [Regression of human cerebellar ataxia under long term administration of 5-hydroxytryptophan].
    Trouillas P; Garde A; Robert JM; Adeleine P
    C R Seances Acad Sci III; 1981 Jan; 292(1):119-22. PubMed ID: 6786764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases.
    Wessel K; Hermsdörfer J; Deger K; Herzog T; Huss GP; Kömpf D; Mai N; Schimrigk K; Wittkämper A; Ziegler W
    Arch Neurol; 1995 May; 52(5):451-5. PubMed ID: 7733838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic trial in a family with late cerebellar atrophy].
    Gracia Naya M; Pina Latorre MA
    Neurologia; 1991 May; 6(5):188-9. PubMed ID: 1908256
    [No Abstract]   [Full Text] [Related]  

  • 6. Regression of cerebellar syndrome with long-term administration of 5-HTP or the combination 5-HTP-benserazide.
    Trouillas P
    Ital J Neurol Sci; 1984 Sep; 5(3):253-66. PubMed ID: 6334064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regression of the cerebellar syndrome under long-term administration of 5-HTP or the combination of 5-HTP and benserazide. 26 cases quantified and treated using computer methods].
    Trouillas P; Garde A; Robert JM; Renaud B; Adeleine P; Bard J; Brudon F
    Rev Neurol (Paris); 1982; 138(5):415-35. PubMed ID: 6983101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of chronic 5-hydroxy-tryptophan in parkinsonian instability of gait and balance and in other neurological disorders.
    Klein P; Lees A; Stern G
    Adv Neurol; 1987; 45():603-4. PubMed ID: 3493632
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebeller ataxia.
    Trouillas P
    Arch Neurol; 1990 Jan; 47(1):12. PubMed ID: 2403786
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing.
    Trouillas P; Brudon F; Adeleine P
    Arch Neurol; 1988 Nov; 45(11):1217-22. PubMed ID: 3190503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of buspirone, a serotonergic 5-HT-1A agonist in cerebellar ataxia: a pilot study. Preliminary communication].
    Trouillas P; Xie J; Getenet JC; Adeleine P; Nighoghossian N; Honnorat J; Riche G; Derex L
    Rev Neurol (Paris); 1995 Dec; 151(12):708-13. PubMed ID: 8787101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ramsay-Hunt syndrome and aniridia in 2 monozygotic twins].
    Chazot G; Guard O; Setiey A; Robert JM; Schott B
    Rev Neurol (Paris); 1975 Jan; 131(1):43-8. PubMed ID: 1080872
    [No Abstract]   [Full Text] [Related]  

  • 13. Levorotatory form of 5-hydroxytryptophan in Friedreich's ataxia. Results of a double-blind drug-placebo cooperative study.
    Trouillas P; Serratrice G; Laplane D; Rascol A; Augustin P; Barroche G; Clanet M; Degos CF; Desnuelle C; Dumas R
    Arch Neurol; 1995 May; 52(5):456-60. PubMed ID: 7733839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoclonus, ataxia, and hypoventilation: response to L-5-hydroxytryptophan.
    Feit H; Kirkpatrick J; Van Woert MH; Pandian G
    Neurology; 1983 Jan; 33(1):109-12. PubMed ID: 6600288
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of cerebellar ataxia.
    Jones TM; Shaw JD; Sullivan K; Zesiewicz TA
    Neurodegener Dis Manag; 2014; 4(5):379-92. PubMed ID: 25405651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A treatment for ataxia.
    Currier RD
    Arch Neurol; 1995 May; 52(5):449. PubMed ID: 7733837
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral choline in cerebellar ataxia.
    Sehested P; Lund HI; Kristensen O
    Acta Neurol Scand; 1980 Aug; 62(2):124-6. PubMed ID: 7211160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral choline in cerebellar ataxia.
    Legg N
    Br Med J; 1979 Jul; 2(6182):133. PubMed ID: 380770
    [No Abstract]   [Full Text] [Related]  

  • 19. Thiamine-responsive acute cerebellar ataxia following febrile illness.
    Adamolekun B; Eniola A
    Cent Afr J Med; 1993 Feb; 39(2):40-1. PubMed ID: 8261503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid in cerebellar ataxia.
    Bhardwaj PK; Bhardwaj I
    J Assoc Physicians India; 1995 Sep; 43(9):657. PubMed ID: 8773082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.